Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Here, we report steroid-free efficacy and safety with tofacitinib among patients with UC who received corticosteroids at baseline of the maintenance study (OCTAVE Sustain). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Vavricka, Stephan R., Greuter, Thomas, Cohen, Benjamin L., Reinisch, Walter, Steinwurz, Flavio, Fellmann, Marc, Guo, Xiang, Lawendy, Nervin, Paulissen, Jerome, Peyrin-Biroulet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096189/
https://www.ncbi.nlm.nih.gov/pubmed/35574426
http://dx.doi.org/10.1177/17562848221090834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096189/
https://www.ncbi.nlm.nih.gov/pubmed/35574426
http://dx.doi.org/10.1177/17562848221090834

Ejemplares similares